Cargando…

IgA Nephropathy with Macroproteinuria and a GFR of 20-30 ml/min/1.73 m(2) May Still Benefit from RAS Inhibition

INTRODUCTION: There has been controversy about renin-angiotensin system (RAS) inhibition in IgAN patients with advanced (stage 4) chronic kidney disease (CKD). Therefore, we investigated the effect of RAS blockade in these patients. METHODS: Renal specimens of 50 IgAN patients who underwent renal bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ying, Jiang, Shimin, Zou, Guming, Zhuo, Li, Li, Wenge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822756/ https://www.ncbi.nlm.nih.gov/pubmed/36660420 http://dx.doi.org/10.1155/2022/9162427

Ejemplares similares

Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m(2) or on Renal Replacement Therapy
por: Estiverne, Christopher, et al.
Publicado: (2020)

Is it necessary to discontinue metformin in diabetic patients with GFR > 60 ml/min per 1.73 m(2) undergoing coronary angiography: A controversy still exists?
por: Namazi, Mohammad Hasan, et al.
Publicado: (2018)

Association between 24h Urinary Sodium and Potassium Excretion and Estimated Glomerular Filtration Rate (eGFR) Decline or Death in Patients with Diabetes Mellitus and eGFR More than 30 ml/min/1.73m(2)
por: Nagata, Takanobu, et al.
Publicado: (2016)

Is There a Nonlinear Relationship between Serum Uric Acid and Lipids in a Hypertensive Population with eGFR ≥30 ml/min/1.73 m(2)? Findings from the China Hypertension Registry Study
por: Yu, Yu, et al.
Publicado: (2020)

Changes in renal function over time in outpatients with eGFR ≥ 30 mL/min/1.73 m(2): implication for timing of renal function testing before contrast-enhanced CT imaging
por: Kuwatsuru, Yoshiki, et al.
Publicado: (2023)

Association of Obesity and Kidney Function Decline among Non-Diabetic Adults with eGFR > 60 ml/min/1.73m(2): Results from the Multi-Ethnic Study of Atherosclerosis (MESA)
por: Malkina, Anna, et al.
Publicado: (2013)

Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m(2)): a proof-of-concept study
por: Donate-Correa, Javier, et al.
Publicado: (2023)

Effect of finerenone on diabetic kidney disease outcomes with estimated glomerular filtration rate below 25 mL/min/1.73 m(2)
por: Mima, Akira, et al.
Publicado: (2023)

Decreased cortical thickness, as estimated by a newly developed ultrasound device, as a risk for vertebral fracture in type 2 diabetes mellitus patients with eGFR of less than 60 mL/min/1.73 m(2)
por: Mishima, T., et al.
Publicado: (2014)

Activation of Complement Pathways in Kidney Tissue May Mediate Tubulointerstitial Injury in Diabetic Nephropathy
por: Jiang, Shimin, et al.
Publicado: (2022)

Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function
por: Tan, Min, et al.
Publicado: (2019)

High-normal albuminuria is associated with subclinical atherosclerosis in male population with estimated glomerular filtration rate ≥60 mL/min/1.73 m(2): A cross-sectional study
por: Kimura, Tomoe, et al.
Publicado: (2019)

Activation of complement C1q and C3 in glomeruli might accelerate the progression of diabetic nephropathy: Evidence from transcriptomic data and renal histopathology
por: Jiao, Yuanyuan, et al.
Publicado: (2022)

The Treatment Effectiveness Evaluation for Slowing the Progression of Diabetic Nephropathy During Stage 4 Chronic Kidney Disease
por: Yu, Tianyu, et al.
Publicado: (2020)

Glycation Gap Is Associated With Macroproteinuria but Not With Other Complications in Patients With Type 2 Diabetes
por: Cosson, Emmanuel, et al.
Publicado: (2013)

Anti-glomerular basement membrane disease mediated by IgG and IgA: a case report
por: Zou, Guming, et al.
Publicado: (2021)

Complement Deposition Predicts Worsening Kidney Function and Underlines the Clinical Significance of the 2010 Renal Pathology Society Classification of Diabetic Nephropathy
por: Jiang, Shimin, et al.
Publicado: (2022)

Lung cancer patients with nephropathy as the first manifestation: Literature review and clinical study report
por: Xu, Qianqian, et al.
Publicado: (2022)

A retrospective observational population‐based study to assess the prevalence and burden of illness of type 2 diabetes with an estimated glomerular filtration rate < 90 mL/min/1.73 m(2) in Ontario, Canada
por: Rapattoni, Wally, et al.
Publicado: (2021)

Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus
por: Zhuo, Li, et al.
Publicado: (2013)

Anti-neutrophil cytoplasmic antibody seropositivity in young adults aged up to 35 years: kidney histopathological findings and patient outcomes
por: Jiang, Shimin, et al.
Publicado: (2022)

Safety Evaluation of Remdesivir for COVID-19 Patients with eGFR < 30 mL/min without Renal Replacement Therapy in a Japanese Single-Center Study
por: Umemura, Takumi, et al.
Publicado: (2022)

Mortality Rates Across 25-Hydroxyvitamin D (25[OH]D) Levels among Adults with and without Estimated Glomerular Filtration Rate <60 ml/min/1.73 m(2): The Third National Health and Nutrition Examination Survey
por: Kramer, Holly, et al.
Publicado: (2012)

Factors associated with the progression of mesangial lesions in IgA nephropathy: A comparative analysis of renal re-biopsies
por: Li, Yetong, et al.
Publicado: (2022)

Association of glomerular DNA damage and DNA methylation with one-year eGFR decline in IgA nephropathy
por: Hayashi, Kaori, et al.
Publicado: (2020)

Crescents proportions above 10% are associated with unfavorable kidney outcomes in IgA nephropathy patients with partial crescent formation
por: Di, Dingxin, et al.
Publicado: (2023)

The pyrochlore-type molybdate Pr(2)Mo(1.73)Sc(0.27)O(7)
por: Gall, Philippe, et al.
Publicado: (2012)

High-throughput sequencing analysis of genes encoding the B-lymphocyte receptor heavy-chain CDR3 in renal and peripheral blood of IgA nephropathy
por: Chen, Dapeng, et al.
Publicado: (2019)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy
por: Furuichi, Kengo, et al.
Publicado: (2020)

Single-Nephron GFR in Different Glomerular Basement Membrane Stages of Membranous Nephropathy
por: Okabayashi, Yusuke, et al.
Publicado: (2023)

Inhibition of RAS in diabetic nephropathy
por: Yacoub, Rabi, et al.
Publicado: (2015)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_drui108qogjvtj71n3i6mnjgo2